Skip to main content
. 2024 Sep 11;33(12):3189–3211. doi: 10.1007/s11136-024-03755-4

Table 2.

Characteristics of patient-reported outcome measures

PROM (first reference) Type Construct(s) Target population Mode of administration Items Rating scale Item score Total score
Health-related quality of life
EORTC-QLQ-C30 [97] Disease-specific Health-related quality of life (functional status, symptoms, global health, quality of life, financial impact) Patients with cancer Self-report 30 Item 1–7: no/yes, item 8–28: Likert scale 4-point, item 29–30: Likert scale 7-point 0–100 Score per scale (0–100)
SF-36 [98] Generic Health-related quality of life (physical functioning, role limitations because of physical health problems, bodily pain, social functioning, general mental health, role limitations because of emotional problems, vitality, general health perceptions) Persons 14 years of age and older Self-report or interview 36 Item 4–5: no/yes, other items: scale with Likert scale ranging from 3-point to 7-point 0–100 Scores determined by algorithm (T-score based on norm: general US population)
SF-8 [99] Generic Health-related quality of life (physical functioning, role limitations because of physical health problems, bodily pain, social functioning, general mental health, role limitations because of emotional problems, vitality, general health perceptions) Persons 14 years of age and older Self-report 8 Likert scale 5-point or 6-point 0–100 Scores determined by algorithm (T-score based on norm: general US population)
EQ-5D-3L [100] Generic Health-related quality of life (mobility, self-care, main activity, social relationships, pain, mood) Adults Self-report 5 3 levels and overall rating of health Variable Overall rate of health 0–100, score per level, summary index (based on a formula)
EQ-5D-5L [101] Generic Health (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) Adults Self-report 5 5 levels and overall rating of health Variable Overall rate of health 0–100, score per level, summary index (based on a formula)
FACT-G [102] Disease-specific Health-related quality of life (physical, social, emotional and functional well-being) Patients with cancer Self-report 27 Likert scale 5-point 0–4 Weighted score per subscale, transformed to overall score of 0–108
PROMIS -Global Health [103] Generic Health (physical function, fatigue, pain, emotional distress, and social health) Adults Self-report 10 Likert scale 5-point Variable One score for physical health and one score for mental health
Functional status
TESS [11] Disease-specific Functional status Adult musculoskeletal oncology Self-report 57 (28 UE and 29 LE) Likert scale 5-point Weighted 0–100
LEFS [104] Disease-specific Functional status Patients with any LE musculoskeletal condition Self-report 20 Likert scale 5-point 0–4 0–80
MHQ [105] Disease-specific Functional status Patients with hand disorders Self-report 37 Raw score per scale (in total 6 different scales), which is converted to a score 0–100 Weighted 0–100, the sum of each scale divided by 6
FAOS [106] Disease-specific Functional status Patients with foot and ankle problems Self-report 42 Likert scale 5-point, 5 subscales 0–4 Raw scores of the 5 subscales transformed to 0–100
SMFA [107] Disease-specific Functional status Patients with musculoskeletal disease Self-report 46 Two scales (34 and 12 items), Likert scale 5-point (1–5) 1–5 Sum of scales transformed by formula to 0–100
QuickDASH [108] Disease-specific Functional status and symptoms Patients with any or multiple disorders of the UE Self-report 11 Likert scale 5-point 1–5 Sum of responses transformed by formula to 0–100
PROMIS -Physical function [103] Generic Physical function Adults Self-report Item bank 124; short form 10 Likert scale 5-point Variable T-score (score of 50 equals the mean of the US population)
Symptoms
BPI-SF [109] Generic Pain Adults Self-report 9 Item 1: no/yes, item 2: body diagram, item 3–6 and 8–9: Likert scale 0–10, item 7: open-ended question 0–10 Per subscale (pain severity and pain interference): mean of Likert scale (0–10)
LENT-SOMA [110] Disease-specific Late toxicity of radiation therapy Patients with cancer Self-report or interview 37 Likert scale 4-point 1–4 None, all criteria are described separately
ISI [111] Generic Insomnia Adults with insomnia complaints Self-report 7 Likert scale 5-point 0–4 Summary of scores per item
MFI-20 [112] Generic Fatigue (general fatigue, physical fatigue, reduced activity, reduced motivation, mental fatigue) Adults Self-report 20 Likert scale 5-point 1–5 Score per scale (4–20)
NRS [113] Generic Pain Adults Self-report 1 Likert scale 11-point 0–10 0–10
MIDOS [114] Disease-specific Symptoms (pain, drowsiness, nausea, constipation, dyspnea, lymphedema, weakness, anxiety, well-being) Palliative patients Self-report 16 Likert scale 4-point 0–3 Summary of scores per item (0–48)
MDASI [115] Disease-specific Symptoms (severity and interference) Patients with cancer Self-report or interview 19 Likert scale 11-point 0–10 Per subscale (mean or summary of scores)
MSAS-SF [116] Disease-specific Symptoms (global distress, physical symptom distress, psychological symptom distress) Patients with cancer Self-report 32 Likert scale 5-point 0–4 Per subscale (mean: 0–4)
Three-item Cancer-Related Symptoms Questionnaire [17] Disease-specific Pain, cough, shortness of breath Metastatic sarcomas Self-report 3 Mild-moderate-severe (%) None (%) None
PROMIS—Pain Interference [103] Generic Pain Adults Self-report Item bank 41; short form 6 Likert scale 5-point Variable T-score (score of 50 equals the mean of the US population)
PROMIS—Fatigue [103] Generic Fatigue Adults Self-report Item bank 95; short form 7 Likert scale 5-point Variable T-score (score of 50 equals the mean of the US population)
PROMIS—Sleep disturbance [103] Generic Sleep Adults Self-report Item bank 27; short form 8 Likert scale 5-point Variable T-score (score of 50 equals the mean of the US population)
FACIT-F [117] Disease-specific Fatigue Patients with chronic (oncologic) illnesses Self-report 13 Likert scale 5-point 0–4 Individual item score multiplied by 13, divided by number of items answered
PRO-CTCAE [118] Disease-specific Symptoms Patients on cancer clinical trials Self-report 124 Likert scale 5-point 0–4 None, score per attribute
Mental wellbeing
HADS [119] Generic Anxiety, depression Patients in a non-psychiatric hospital department Self-report 14 Likert scale 4-point 0–3 Per subscale (anxiety/depression): summary of scores
CWS [120] Disease-specific Cancer worries Patients with cancer Self-report 8 Likert scale 4-point 1–4 8–32
IES [121] Generic Stress Adults Self-report 15 (7 intrusion and 8 avoidance items) 0 (not at all)—1 (rarely)—3 (sometimes)—5 (often) 0–1-3–5 Per subscale (intrusion: 0–35 and avoidance: 0–40), summary of scores (0–75)
NCCN Distress Thermometer [122] Disease-specific Distress Patients with cancer Self-report 1 Likert scale 11-point 0–10 0–10
WHO-5 [123] Generic Mental wellbeing Children aged 9 and above Self-report 5 Likert scale 6-point 0–5 0–25
PROMIS—Depression [103] Generic Depression Adults Self-report Item bank 28; short form 8 Likert scale 5-point Variable T-score (score of 50 equals the mean of the US population)
PROMIS—Anxiety [103] Generic Anxiety Adults Self-report Item bank 29; short form 7 Likert scale 5-point Variable T-score (score of 50 equals the mean of the US population)
WEMWBS [124] Generic Mental wellbeing Adults Self-report 14; short form 7 Likert scale 5-point 1–5 Summing the scores of each of the items
FoP-Q-SFa Disease-specific Fear of progression Patients with cancer Self-report 12 Likert scale 5-point 1–5 12–60
Social wellbeing
RNL [125] Generic Participation (mobility, self-care, daily activity, recreational activity, family roles) Adults after incapacitating illness or severe trauma Self-report 11 Likert scale 10-point 1–10 Summary of scores (maximum 110), proportionally converted to a 100-point scale
PROMIS—Ability to participate [103] Generic Social function Adults Self-report Item bank 14; short form 7 Likert scale 5-point Variable T-score (score of 50 equals the mean of the US population)

US United States of America, UE upper extremity, LE lower extremity, PROM patient-reported outcome measure

aFull-text of development study not available